Spinal PKC activity and expression: Role in tolerance produced by continuous spinal morphine infusion

Pain

Volumn 85, Issue 3, 2000, Pages 395-404

  Granados Soto, Vinicio ^a   Kalcheva, Iveta ^a   Hua, Xiao Ying ^a   Newton, Alexandra ^a   Yaksh, Tony L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chelerythrine; Morphine; Protein kinase C; Spinal; Tolerance

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; BISINDOLYLMALEIMIDE; CHELERYTHRINE; MORPHINE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOBLOTTING; MALE; MORPHINE TOLERANCE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; THERMAL STIMULATION;

ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; ENZYME INHIBITORS; IMMUNOBLOTTING; INJECTIONS, SPINAL; ISOENZYMES; MALE; MORPHINE; NARCOTICS; PAIN MEASUREMENT; PHENANTHRIDINES; PHOSPHORYLATION; POSTERIOR HORN CELLS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 0034176522     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00281-X     Document Type: Article

References (43)

1. Bachrach U., Benalal D., Reches A. Morphine inhibits cyclic AMP-dependent protein kinase and ornithine decarboxylase activities in neuroblastoma×glioma hybrid cells. Life Sci. 25:1979;1879-1883.
2. Bhargava H.N. Attenuation of tolerance to, and physical dependence on, morphine in the rat by inhibition of nitric oxide synthase [Published erratum appears in Gen Pharmacol 96 Apr;27(3):557]. Gen Pharmacol. 26:1995;1049-1053.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
4. Chakrabarti S., Wang L., Tang W.J., Gintzler A.R. Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence. Mol Pharmacol. 54:1998;949-953.
5. Chen L., Huang L.Y. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron. 7:1991;319-326.
6. Collingridge G.L., Bliss T.V. Memories of NMDA receptors and LTP. Trends Neurosci. 18:1995;54-56.
7. Dirig D.M., Salami A., Rathbun M.L., Ozaki G.T., Yaksh T.L. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods. 76:1997;183-191.
8. Dunbar S.A., Yaksh T.L. Concurrent spinal infusion of MK8Ol blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat [published erratum appears in Anesthesiology 96 Sep;85(3):695]. Anesthesiology. 84:1996;1177-1188.
9. Dunbar S.A., Yaksh T.L. Spinal infusion of N-methyl-D-aspartate antagonist MK801 induces hypersensitivity to the spinal alpha-2 agonist 5T91 in the rat. J Pharmacol Exp Ther. 281:1997;1219-1225.
10. Dunbar S.A., Pulai I.J. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat. J Pharmacol Exp Ther. 284:1998;678-686.
11. Ferguson S.S., Barak L.S., Zhang J., Caron M.G. G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can J Physiol Pharmacol. 74:1996;1095-1110.
12. Gouarderes C., Thamandas K., Cridland R., Cros J., Quirion R., Zajac J.M. Opioid and substance P receptor adaptations in the rat spinal cord following sub-chronic intrathecal treatment with morphine and naloxone. Neuroscience. 54:1993;799-807.
13. Graff J.M., Stumpo D.J., Blackshear P.J. Molecular cloning, sequence, and expression of a cDNA encoding the chicken myristoylated alanine-rich C kinase substrate (MARCKS). Mol Endocrinol. 3:1989;1903-1906.
14. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
15. Herbert J.M., Augereau J.M., Gleye J., Maffrand J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 172:1990;993-999.
16. Ibuki T., Dunbar S.A., Yaksh T.L. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion. Pain. 70:1997;125-132.
17. Jhamandas K.H., Marsala M., Ibuki T., Yaksh T.L. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine. J Neurosci. 16:1996;2758-2766.
18. Katada T., Gilman A.G., Watanabe Y., Bauer S., Jakobs K.H. Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem. 151:1985;431-437.
19. Kikkawa U., Takai Y., Minakuchi R., Inohara S., Nishizuka Y. Calcium-activated, phospholipid-dependent protein kinase from rat brain. Subcellular distribution, purification, and properties. J Biol Chem. 257:1982;13341-13348.
20. Lefkowitz R.J. G protein-coupled receptor kinases. Cell. 74:1993;409-412.
21. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci. 14:1994;2301-2312.
22. Mao J., Price D.D., Phillips L.L., Lu J., Mayer D.J. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res. 677:1995;257-267.
23. Mayer D.J., Mao J., Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain. 61:1995;365-374.
24. Narita M., Feng Y., Makimura M., Hoskins B., Ho I.K. A protein kinase inhibitor, H-7, inhibits the development of tolerance to opioid antinociception. Eur J Pharmacol. 271:1994;543-545.
25. Narita M., Makimura M., Feng Y., Hoskins B., Ho I.K. Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res. 650:1994;175-179.
26. Narita M., Mizoguchi H., Tseng L.F. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu- opioid receptor agonist in the mouse. Eur J Pharmacol. 280:1995;R1-R3.
27. Narita M., Mizoguchi H., Kampine J.P., Tseng L.F. Role of protein kinase C in desensitization of spinal delta-opioid-mediated antinociception in the mouse. Br J Pharmacol. 118:1996;1829-1835.
28. Nestler E.J. Cellular responses to chronic treatment with drugs of abuse. Crit Rev Neurobiol. 7:1993;23-39.
29. Newton A.C. Protein kinase C: structure, function, and regulation. J Biol Chem. 270:1995;28495-28498.
30. Nishino K., Su Y.F., Wong C.S., Watkins W.D., Chang K.J. Dissociation of mu opioid tolerance from receptor down-regulation in rat spinal cord. J Pharmacol Exp Ther. 253:1990;67-72.
31. Polgár E., Fowler J.H., McGill M.M., Todd A.J. The types of neuron which contain protein kinase C gamma in rat spinal cord. Brain Res. 833:1999;71-80.
32. Roerig S.C., Fujimoto J.M. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. J Pharmacol Exp Ther. 249:1989;762-768.
33. Rowland M., Tozer T.N. Clinical pharmacokinetics: concept and application. 1995;Williams and Wilkins, Media, PA.
34. Sosnowski M., Yaksh T.L. Differential cross-tolerance between intrathecal morphine and sufentanil in the rat [see comments]. Anesthesiology. 73:1990;1141-1147.
35. Stevens C.W., Yaksh T.L. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord. J Pharmacol Exp Ther. 251:1989;216-223.
36. Takano Y., Yaksh T.L. Chronic spinal infusion of dexmedetomidine, ST-91 and clonidine: spinal alpha 2 adrenoceptor subtypes and intrinsic activity. J Pharmacol Exp Ther. 264:1993;327-335.
37. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 266:1991;15771-15781.
38. Wong C.S., Su Y.F., Watkins W.D., Chang K.J. Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes. J Pharmacol Exp Ther. 262:1992;317-326.
39. Yaksh T.L. The spinal action of opioids. Hertz A. Handbook of experimental pharmacology. 1993;53-90 Springer, Heidelberg.
40. Yaksh T.L., Onofrio B.M. Retrospective consideration of the doses of morphine given intrathecally by chronic infusion in 163 patients by 19 physicians. Pain. 31:1987;211-223.
41. Yaksh T.L., Rudy T.S. Chronic catheterization of the spinal subarachnoid space. Physiol Behav. 17:1976;1031-1036.
42. Zhang L., Yu Y., Mackin S., Weight F.F., Uhl G.R., Wang J.B. Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem. 271:1996;11449-11454.
43. Zhang J., Ferguson S.S., Barak L.S., Bodduluri S.R., Laporte S.A., Law P.Y., Caron M.G. Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA. 95:1998;7157-7162.